Location
United States, North America
Check Size
$500K - $15M
Investment Stage
Series B
Focus Areas
BioTech
Enterprise
Pharmaceuticals
About Investor
Tuyen Ong is a CEO-Partner at Flagship Pioneering, investing primarily in Series B life sciences and biotech ventures, with typical checks ranging between $500K and $15M. His most recent investment, Ring Therapeutics, focuses on next-generation gene therapy using commensal virome vectors. He draws from a strong pharmaceutical and biotech background, having previously served as SVP and Head of Ophthalmology at Biogen and as Chief Development Officer at Nightstar Therapeutics.
Previous investments
Ring Therapeutics
87M |2023
120M |2021
Similar Investors
RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,FF
Faraz Fatemi
United States, North America
$1M - $30M
Seed
,Series A
,VL
Vishal Lugani
United States, North America
$700K - $7M
Seed
,Series A
,CG
Chian Gong
United States, North America
$250K - $10M
Pre Seed
,Seed
,GR
Gokul Rajaram
United States, North America
$25K - $1M
Pre Seed
,Seed
,WC
Wayne Chang
United States, North America
$10K - $500K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP